经导管主动脉瓣置换术后红细胞输注与临床结局的关联
该回顾性研究分析了429例接受经导管主动脉瓣置换的重度主动脉瓣狭窄患者,采用倾向评分校正的多变量模型,发现术后输注浓缩红细胞与30天及院内死亡、心肌梗死或卒中复合终点以及1年死亡率独立相关。
要点
- 术后输注红细胞与30天和院内死亡、心梗或卒中复合终点风险升高相关
- 术后输注红细胞与1年死亡率独立相关(HR 2.65)
- 需权衡输血利弊,优化围术期血液管理
核心结论
- 经导管主动脉瓣置换术后输注浓缩红细胞与住院期间、30天及1年随访不良结局发生率增加相关。
研究设计与样本
- 回顾性分析429例接受经导管主动脉瓣置换的重度主动脉瓣狭窄患者,采用倾向评分校正的多变量logistic和Cox回归模型。
主要发现
- 输血组较未输血组30天死亡、心肌梗死或卒中复合终点风险升高(HR 2.03,95%CI 1.02-4.07,P=0.045)。
- 输血组较未输血组院内死亡、心肌梗死或卒中复合终点风险升高(HR 2.46,95%CI 1.12-5.41,P=0.025)。
- 术后输血与1年死亡率独立相关(HR 2.65,95%CI 1.21-5.80,P=0.015)。
临床怎么用
- 在TAVR围术期应审慎评估输血指征,加强血液保护策略以减少不必要的红细胞输注。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: We evaluated the association between postprocedural packed red blood cell transfusion and morbidity and mortality among patients undergoing transcatheter aortic valve replacement. METHODS: We retrospectively analyzed 429 patients with severe aortic stenosis who underwent transcatheter aortic valve replacement. Propensity-score adjusted multivariable logistic and Cox regression models were used to determine the association of packed red blood cell transfusion with the composite endpoint of death, myocardial infarction, and stroke at 30 days and in hospital, and 1-year mortality. RESULTS: Patients receiving transfusions had a higher 30-day and in-hospital incidence of death, myocardial infarction, or stroke when compared with patients who did not receive transfusions (hazard ratio 2.03, 95% confidence interval: 1.02 to 4.07, p = 0.045; and hazard ratio 2.46, 95% confidence interval: 1.12 to 5.41, p = 0.025, respectively). Postprocedural transfusion was independently associated with 1-year mortality (hazard ratio 2.65, 95% confidence interval: 1.21 to 5.80, p = 0.015). CONCLUSIONS: Packed red blood cell transfusion for patients undergoing transcatheter aortic valve replacement is associated with an increased incidence of adverse outcomes during hospitalization and at 30-day and 1-year follow-up.
引用
- Apostolidou E, Aronow HD, Beale CE, et al. Association Between Red Blood Cell Transfusion and Clinical Outcomes Among Patients Undergoing Transcatheter Aortic Valve Replacement. Ann Thorac Surg. 2018. PMID: 30552884. doi:10.1016/j.athoracsur.2018.11.022
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。